Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YFZ-3YH
- Development stage
- Preclinical
- Lead developer
- Yifan Pharmaceutical
- Administration
- Oral
01
Overview
YFZ-3YH is an investigational traditional Chinese medicine (TCM) candidate being developed by Yifan Pharmaceutical. It is currently in preclinical development for the treatment of syndromes characterized by Qi and blood deficiency and blood stasis. In the framework of traditional Chinese medicine, these conditions are often associated with chronic fatigue, pallor, and impaired circulation. The formulation is designed to tonify Qi (vital energy), nourish blood, and invigorate blood flow to resolve stasis. As a TCM product, it likely consists of a complex mixture of herbal extracts that work synergistically across multiple biological pathways rather than targeting a single molecular entity.
Beyond the preview
Go deeper on YFZ-3YH.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on YFZ-3YH.